AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Bionano Genomics, Inc. Director's Dealing 2021

Oct 20, 2021

35041_dirs_2021-10-20_de6966ed-0d9d-4101-99ee-aa68b2cd020b.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Bionano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2021-10-18

Reporting Person: Shams Soheil (Chief Informatics Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities are beneficially owned	0	Direct